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Abstract: Ephedra alata Decne. belongs to the Ephedraceae family. It is a species of Ephedra that grows
mostly in the desert. Today, the main importance of Ephedra species in the medical field is due to the
presence of the alkaloids derived from phenyl-alanine, which act on the sympathetic nervous system
as a sympathomimetic. The aim of this study was to conduct a phytochemical characterization of
the hydroalcoholic extract of the aerial part of Ephedra alata Decne., which is indigenous to Tunis,
that involves the total phenolic content, individual phenolic content, and antioxidant activity as
well as a biological screening for the evaluation of the antimicrobial, antifungal, antiproliferative,
pro-apoptotic, and cytotoxic potential against the MCF-7 breast cancer cell line. The results show
that the hydroalcoholic extract contains polyphenolic phytocompounds (156.226 ± 0.5 mgGAE/g
extract) and elicits antioxidant activity (7453.18 ± 2.5 µmol Trolox/g extract). The extract acted
as a bacteriostatic agent against all tested bacterial strains, but was bactericidal only against the
Gram-positive cocci and Candida spp. In the set experimental parameters, the extract presents
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antiproliferative, pro-apoptotic, and cytotoxic potential against the MCF-7 human breast cancer
cell line.
Keywords: Ephedra alata Decne; polyphenols; antioxidant; bacteria; fungi; MCF-7 human breast
cancer cell line
1. Introduction
Throughout history, the Plant Kingdom has represented a significant source for the discovery of
new drugs with important therapeutic effects in different areas of medicine. Various types of plant
extracts include a large range of phytochemicals, which can be—on their own or through a synergistic
mechanism—useful for different therapeutic activities. At the moment, many of the currently used
drugs in well-established therapeutic protocols are directly obtained from, or are chemical derivatives
of, phytochemicals [1].
Ephedra alata Decne. belongs to the Ephedraceae family. It is a species of Ephedra that grows
mostly in the desert. The genus Ephedra is known to comprise approximately 40 species that populate
arid environments, especially those from the northern hemisphere and the south part of America [2].
Ephedra species have a long history in traditional Chinese medicine (approximately 5000 years), with
uses in the treatment of allergies, nasal congestion, bronchial asthma, coughs, and flu [3]. The drug is
known under the name of Ma-huang. The drug was traditionally obtained from the dry stems of three
Ephedra species, namely Ephedra sinica, Ephedra intermedia, and Ephedra equisetina, and is nowadays sold
in health food stores in the West as a herbal mixture, known under the name of Herbal Ecstasy, that is
proclaimed to have energizing value [4]. Today, the main importance of Ephedra species in the medical
field is due to the presence of the alkaloids derived from phenyl-alanine (e.g., ephedrine and other
related compounds, such as pseudoephedrine, norpseudoephedrine, norephedrine, methylephedrine,
and methylpseudoephedrine), which acts on the sympathetic nervous system as a sympathomimetic [5].
It was reported in the literature that the aerial parts of this plant contain between 0.02 and 3.4% nitrate
compounds, with (−)ephedrine being the main isomer detected (between 30 and 90%) [6]. Ephedrine is
a medicine that is used to prevent arterial hypotension during spinal anesthesia. It is commonly
employed as nasal decongestant, and has appetite-suppressant properties [7]. Besides this class of
phytochemicals, the plant extract represents a source of polyphenolic compounds, which provide it
with significant antioxidant properties [8]. Flavones, flavanols, bisflavanols, and carboxylic acids were
reported to be the main phytochemicals along with alkaloids by the group of Abourashed et al. [6].
Also, essential oil has been indicated to be among the main components of this plant [9].
The literature describes some studies on the biological activity of Ephedra species. Extracts or
fractions from callus cultures or wild plants from different species of Ephedra were reported to have
antioxidant, antimicrobial, and antifungal properties [10,11]. Pullela et al. have isolated four lignans
from Ephedra viridis Coville and screened these compounds for antioxidant and estrogenic activity
and a possible cytotoxic effect against a number of human leukemia cells and solid tumors. The study
concluded that the compounds elicited moderate free radical scavenging properties, no cytotoxicity,
and estrogenic activity [12]. Nam et al. have shown that a water fraction of Ephedra sinica Stapf.
has manifested anti-invasive, antiangiogenic, and antitumour effects in a mouse model of murine
melanoma [13]. The hydroalcoholic extract obtained from Ephedra campylopoda C.A.Mey. has been
assigned antioxidant, antibacterial, and in vitro antiproliferative properties against the HT 29 and HCT
116 colon cancer cell lines [14]. Ephedra fragilis Desf. extract elicited immunostimulant activity in an
in vitro model using human peripheral lymphocytes [15]. Ephedra alata L. turned out to be a promising
agent for a biologically based strategy for the inhibition of growth as well as aflatoxin production by
Aspergillus flavus mold [16].
Molecules 2019, 24, 13 3 of 15
The aim of this study was to conduct a phytochemical characterization of the hydroalcoholic
extract of the aerial part Ephedra alata Decne., which is indigenous to Tunis, that involves the total
polyphenols content, individual polyphenols content, and antioxidant activity as well as a biological
screening for an evaluation of the extract’s antimicrobial, antifungal, antiproliferative, pro-apoptotic,
and cytotoxic potential against the MCF-7 breast cancer cell line.
2. Results
2.1. Phytochemical Composition
In order to determine the phytochemical composition, the total phenolic content (TP), individual
phenolic content, antioxidant activity (AA), and total alkaloids (TA) were screened. The phytochemical
composition of the hydroalcoholic extract of the aerial part of Ephedra alata Decne. (EA), determined
by UV-VIS spectrometry, is presented in Table 1. The individual polyphenols and LC-MS parameters
of the hydroalcoholic extract of the aerial part of Ephedra alata Decne. (EA) are presented in Table 2.
Table 1. The total phenolic content (TP), antioxidant activity (AA), and total alkaloids (TA) of the
hydroalcoholic extract of the aerial part of Ephedra alata Decne. (EA).
Sample TP(mgGAE/g Extract)
AA
(µmol Trolox/g Extract)
TA
(mg Ephedrine/g Extract)
EA 156.226 ± 0.5 7453.18 ± 2.5 17.57 ± 0.6
The individual polyphenols were detected using different extraction conditions and identified on
two different chromatographic columns (Figure 1 and Table 2). The screened compounds were gallic
acid, protocatecuic acid, caffeic acid, coumaric acid, ferulic acid, rosmarinic acid, epicatechin, rutin,
resveratrol, quercetin, and kaempherol.
Figure 1. An LC-MS chromatogram of the hydroalcoholic extract of the aerial part of Ephedra alata
Decne. (EA).
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Table 2. The individual polyphenols of the hydroalcoholic extract of the aerial part of Ephedra alata
Decne. (EA), and the LC-MS parameters.
Compounds
Retention
Time
Column I
(min)
Retention
Time
Column II
(min)
m/z
Signal
EA in Hydroethanolic Extract EA in Hydromethanolic Extract
Chromatographic Column I Calibration
Curve
Column I Column II
µg/mL± SD
(µg/mg)
µg/mL± SD
(µg/mg) (µg/mL± SD) (µg/mg)
Gallic acid 4.826 4.745 169 nd nd nd y = 8.470 e-006x(r = 0.9996);
Protocatecuic acid 11.982 11.774 153 nd nd nd y = 8.036 e-006x(r = 0.9990);
Caffeic acid 18.605 18.396 179 0.709 ± 0.279(0.014) nd 0.389 ± 0.49 (0.008)
y = 7.110 e-006x
(r = 0.9990);
Epicatechin 22.910 23.242 289 nd 7.736 ± 0.297(0.155) nd
y = 3.881 e-005x
(r = 0.9996);
p-coumaric acid 24.374 24.454 163 0.241 ± 0.028(0.005) nd 0.261 ± 0.021 (0.005)
y = 1.1566 e-006x
(r = 0.9997);
Ferulic acid 26.333 24.883 193 nd nd nd y = 1.172 e-006x(r = 0.9999);
Rutin 27.290 26.086 609 nd nd nd y = 1.813 e-005x(r = 0.9999)
Rosmarinic acid 28.252 29.129 359 0.915 ± 0.008(0.018)
0.397 ± 0.002
(0.008) 0.807 ± 0.049 (0.016)
y = 1.018 e-006x
(r = 0.9982);
Resveratrol 29.749 29.887 227 9.403 ± 0.008(0.188)
12.963 ± 0.454
(0.259) 10.387 ± 0.422 (0.207)
y = 6.388 e-006x
(r = 0.9945);
Quercitin 32.591 31.841 301 2.873 ± 0.70(0.057)
2.387 ± 0.06
(0.048) 4.572 ± 0.384 (0.091)
y = 1.001 e-005x
(r = 0.9992);
Kaempferol 34.470 34.378 285 24.297 ± 2.73(0.485)
6.814 ± 0.179
(0.136) 28.675 ± 2.579 (2.867)
y = 3.273 e-005x
(r = 0.9990).
nd = not detected.
In the ethanolic extracts of EA, individual polyphenols were determined using two different
C18 chromatographic columns under the same operating conditions. The compounds identified on
both columns were: rosmarinic acid (mean value, 0.013 µg/mg), resveratrol (0.223 µg/mg), quercitin (2.63
µg/mg), and kampherol (15.55 µg/mg). Caffeic acid (0.014 µg/mg) and p-coumaric acid (0.05 µg/mg)
were identified in small quantities. These compounds were identified only on the Adsorbosphere UHS
C18 column, while epicatechin was identified on the NUCLEODUR C18 Gravity SB column.
In the methanolic extract, rosmarinic acid (0.016 µg/mg), resveratrol (0.207 µg/mg), quercitin
(0.091 µg/mg), kampherol (2.867 µg/mg), caffeic acid (0.008 µg/mg), and p-coumaric acid (0.005
µg/mg) were detected. Gallic acid, protocatechuic acid, and ferulic acid were not detected in either of
the two analyzed extracts.
2.2. Antimicrobial Activity
Another aim of the study was to screen EA for antimicrobial activity. The antibacterial activity
of this extract was established according to the standardized value of the positive control (15 mm for
gentamycin and 17 mm for fluconazole). All Gram-negative bacilli strains and Enterococcus faecalis were
resistant to the test extract. The Staphylococcus aureus and Candida strains had insignificant inhibitory
activity at the screened concentration. The inhibition diameters are presented in Table 3.
Table 3. The inhibition diameters for selected strains after incubation with 30 µg/ml of EA.
Compound KlebsiellaPneumonia
Shigella
flexneri
Salmonella
Enterica
Escherichia
coli
Pseudomonas
Aeruginosa
Staphylococcus
Aureus
Enterococcus
Faecalis
Candida
Albicans
Candida
Parapsilosis
EA 7 mm 7 mm 7 mm 7 mm 7 mm 9 mm 7 mm 10 mm 10 mm
Table 4 presents the results on the MIC and MBC. The MIC values for S. aureus and Candida
spp. (50 µg/mL) were lower than those for Gram-negative bacteria (200 µg/mL) and E. faecalis
(100 µg/mL). In addition, the MBC values were 2 times greater than the MIC values. Based on these
results, we can affirm that the extract can act as a bacteriostatic agent against all tested bacterial strains;
however, it is bactericidal only against the Gram-positive cocci and Candida spp.
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Table 4. The Results on the minimum inhibitory concentration (MIC) and the minimum bactericidal
concentration (MBC).
Species MIC (µg/mL) MBC (µg/mL)
K. pneumoniae 200 -
S. flexne 200 -
S. enterica 200 -
E. coli 200 -
P. aeruginosa 200 -
S. aureus 50 100
E. faecalis 100 200
C. albicans 50 100
C. parapsilosis 50 100
2.3. Anticancer Activity
The EA was screened for possible in vitro anticancer activity against the MCF-7 human breast
cancer cell line. The antiproliferative activity of EA at the selected concentrations after a period of
incubation of 72 h is shown in Figure 2. Statistically significant results were detected starting from the
concentration of 10 µg/mL, with a cell growth inhibition percentage of 19.68 ± 4.2. For the highest
tested concentration, namely 30 µg/mL, the growth inhibition percentage was 56.45 ± 3.9.
Figure 2. The cell growth inhibition for the MCF-7 human breast cancer cell line after 72 h of incubation
with EA. SEM, standard error of the mean.
As is already well-known, MTT is a colorimetric assay for assessing the metabolic activity of cells
(the activity of mitochondrial dehydrogenase). In order to see if we can also talk about a possible
cytotoxic effect, the release of lactat dehydrogenase at the highest tested concentration was also
measured. The results are depicted in Figure 3.
Figure 3. The cytotoxicity analysis of EA extract at a concentration of 30 µg/mL on MCF-7 cells (after
72 h of stimulation).
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The cytotoxicity assessment revealed that the EA extract manifested a significant difference in
cytotoxic potential when compared with the positive control, displaying a cytotoxicity percentage
above 13%. The solvent (DMSO) showed no significant cytotoxic potential on MCF-7 cells.
The distribution of the phases of the cell cycle following incubation with EA at the concentration
of 30 µg/ml shows a slight increase in the percentage of cells of the G0/G1 phase (data not shown).
The potential anti-migratory activity of the EA on MCF-7 human breast adenocarcinoma cells
was verified by means of a wound-healing technique, and the results are shown in Figure 4.
Figure 4. The migratory potential of MCF-7 human breast adenocarcinoma cells after treatment with
EA extract at a concentration of 30 µg/mL. The pictures were taken by light microscopy, and the
scale bars represent 100 µm. The bar graphs are expressed as percentage of wound healing after 24 h
compared to the initial surface.
The results indicate that the EA extract had a strong inhibitory effect on the MCF-7 cells’ migration,
showing a wound healing rate below 5% after an interval of 24 h. The solvent (DMSO) was also
analysed for potential anti-migratory activity. It can be observed from Figure 4 that the solvent slowed
down the migratory potential of the MCF-7 cells, inducing a wound closure percentage of almost 17%.
The control cells (cells treated with growth medium) showed a closure of the scratch above 43%.
The cytotoxicity assessment revealed that the EA extract manifested a significant difference in the
cytotoxic potential when compared to the positive control, displaying a cytotoxicity percentage above
13%. The solvent (DMSO) showed no significant cytotoxic potential on MCF-7 cells.
In order to investigate the apoptotic potential of EA at the selected concentration, MCF-7 cells
were treated with 30 µg/mL of EA for 72 h, and the cells’ nuclei were analyzed by DAPI staining.
As shown in Figure 5, the control cells exhibit a normal organization, with a large, round nucleus,
a clear nucleolus, and uniform chromatin density. However, after treatment, the MCF-7 cells manifested
morphological changes distinctive for apoptosis induction, such as chromatin condensation.
Figure 5. The effect of 30 µg/mL of EA on MCF-7 cells’ nuclei after 72 h. Morphological changes
distinctive for apoptosis induction are marked with yellow arrows. For the nuclear visualization, DAPI
staining was performed. The scale bars represent 20 µm.
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Figure 6 presents the evaluation of the pro-apoptotic activity of the MCF-7 human breast cancer
cell line after 72 h of incubation with EA at the concentration of 30 µg/mL (mean values) together with
representative dot-plots. Early apoptosis, late apoptosis, and necrosis can be detected. The highest
number of events was recorded for the process of early apoptosis.
Figure 6. The evaluation of the pro-apoptotic activity of the MCF-7 human breast cancer cell line after
72 h of incubation with EA at the concentration of 30 µg/mL (lower right quadrant: early apoptotic
cells; upper right quadrant: late apoptotic cells; upper left quadrant: necrotic cells).
3. Discussion
The results obtained in this study regarding the phytochemical composition—TA (17.57 mg/g
extract), TP (156.22 mgGAE/g extract), and AA (7453 µmol Trolox/g)—are consistent with those
reported by other authors.
In a comprehensive study on the phytochemical composition of different Ephedra species collected
from the botanical garden of the University of Hamburg, Germany and analyzed as methanolic extracts,
Ibragic and Sofic 2015 have reported the total phenolics content (TP, 53.3 ± 0.1 mg GAE/g dry weight)
and total alkaloids content (TA, 0.2–15.24 mg E/g dry weight) [5].
The group of Jaradat et al. have analyzed the phytochemical composition of the same species
collected from the mountains of Jenin region, Palestine using water, methanol, and ethanol for the
extraction. The study reports that, when water was used, total polyphenols could not be detected in
the extract, while small amounts of flavonoids were detected (0.519 ± 0.09 mg/g Rutin equivalent).
Methanol was found to be the best solvent, leading to 47.62 ± 0.94 mg GAE/g dry weight of total
polyphenols and 54.66 ± 0.12 mg/g Rutin equivalent of total flavonoids. Ethanol had a mild extraction
capacity, leading to 19.175± 0.625 94 mg GAE/g dry weight of total polyphenols and 5.44± 0.625 mg/g
Rutin equivalent of total flavonoids. The antioxidant activity of the extract was ascertained by a DPPH
assay [17]. Jerbi et al. tested different solvents, namely hexane, ethyl acetat, and methanol, for the
extraction, and recorded the highest percentage yield of extraction as well as the highest radical
scavenging potential when methanol was employed [9]. It is well-known that evaporation leads to
solvent removal; however, evaporation may not lead to 100% removal, as trace amounts of solvent
can remain. Although the abovementioned studies showed that methanol extracts better than ethanol,
which is an event that is expected due to polarity, we have chosen ethanol as the solvent in this study
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because of its lack of toxicity within an in vivo environment. In a similar approach, the group of
Al-Rimawi et al. analyzed extracts of Ephedra alata Decne. collected from the southern part of the West
Bank, Palestine using three different solvents, namely water, 100% ethanol, and 80% ethanol, in order
to observe which solvent leads to the highest amount of total polyphenols (TP), the highest amount
total flavonoids (TF), and the highest antioxidant activity (AA). The results showed that the polarity
influences the screened parameters, with 80% ethanol being the best choice in terms of TP (101.2 ±
0.9 mg GAE/g dry weight) and AA (FRAP, 21.3 ± 0.4 mmol Fe+2/g dry weight; CUPRAC, 6442 ± 52
µmol Trolox/g dry weight; DPPH, 482.5 ± 1.7 µmol Trolox/g dry weight; and ABTS, 66.0 ± 1.5 µmol
Trolox/g dry weight). On the other hand, the TF was higher in case of 100% ethanol (19.5 ± 0.3 mg
catechin/g dry weight) [18].
The Ephedra genus is recognized for its high alkaloid content; in particular, alkaloids belonging to
the ephedrine (E) type. However, a small number of studies point towards the composition of individual
polyphenols. In this respect, this paper presents a new approach regarding the phytochemical composition
of EA.
Amakura et al. reported on the main individual polyphenols in EA (cinnamic acid, syringin,
catechin, epicatechin, symplocoside, pollenitin B, herbacetin 7-O-glucoside, kaempferol 3-O-rhamnoside
7-O-glucoside, and isovitexin 2-O-rhamnoside) [19]. The LC-DAD-ESI/MSn profile of E. alata was
characterized by Ziani et al. It indicated the presence of 10 phenolic compounds, all belonging to the
flavonoids class (five isoflavones and five flavones) [20]. Quercitin and kaempferol-3-O-rhamnoside have
also previously been detected in Ephedra dietary supplements [21].
Our results on the polyphenols identified in the hydroalcoholic extracts of EA are consistent with
previous data reported by other researchers, and indicate the presence of quercitin and kaempferol.
The presence of rosmarinic acid in the hydroalcoholic extracts of EA represents a particularity that has
not been reported in previous studies.
Antimicrobial Activity
There is a paucity of studies in the literature on the antimicrobial activity of Ephedra alata
Decne. A few groups, including that of Ghanem et al., have evaluated the antimicrobial activity
of different types of extracts from Ephedra alata, namely water, methanol, and acetonitrile extracts,
against four bacteria (S. aureus, Pseudomonas aeruginosa, Bacillus subtilis, and Escherichia coli) and four
fungi (Aspergillus fumigatus, Penicillium italicum, Syncephalastrum racemosum, and C. albicans). The results
showed that the only extract that was active against both Gram-positive and Gram-negative bacteria,
as well as against fungi, was the acetonitrile extract. The methanolic extract elicited only antifungal
potential, with A. fumigatus and P. italicum being the sensitive strains [22]. Good results for both
Gram-positive and Gram-negative bacteria were obtained with the following solvents: butanol, ethyl
acetate, and dichloromethane [23]. In this study, which analyses the ethanolic extract obtained from
the aerial part of Ephedra alata Decne., we have shown that, among the tested strains, S. aureus and
Candida spp. are the most sensitive strains to EA.
Some species of Ephedra have been assigned anticancer potential against various cell lines.
For example, extracts obtained with different solvents from Ephedra aphylla have shown antiproliferative
activity against the T47D and MCF-7 breast cancer cell lines. The same study showed that the
extracts have weak antiproliferative potential against Vero, a normal kidney cell line [24]. Ephedra
campylopoda stem methanolic and ethanolic extracts elicited an antiproliferative effect on the Jurkat
human leukemic T cell line [25]. The herbal extract of Ephedra initially obtained from Ephedra sinica,
as well as an ephedrine alkaloid-free Ephedra herb extract, has shown antiproliferative potential
against the H1975 non-small-cell lung cancer cell line [26]. Mohamad et al. have presented
data on the antiproliferative effect of Ephedra campylopoda collected from the south of Lebanon on
HT-29 human epithelial cells and HCT116 human colon cancer cells [14]. The cytotoxic effect (at
24 h of incubation) and cytostatic effect (at 72 h of incubation) of Ephedra alata extracts in the range
of 0–1000 µg/mL were analyzed for monocultures and co-cultures of Hepg2 and THP-1-derived
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macrophages. Significant cytotoxic effects were recorded for concentrations higher than 500 µg/mL.
The cytostatic activity was stronger in the co-cultures (an IC50 of 380 µg/mL) [27]. Mendelovich et al.
have shown that ethanolic extracts from the leaves, as well as the fruit juice, of Ephedra foeminea have
significant antiproliferative and pro-apoptotic potential against MDA-MB-231 (human breast cancer),
HCT116 (human colon) and HaCaT (human keratinocytes) cells [28]. In an ethnopharmacological
study, Jaradat et al. concluded, based on questionnaires addressed to women diagnosed with breast
cancer on the West Bank of Palestine, that the leaves and seeds of Ephedra alata, mostly prepared
in the form of a decoction, are the most frequently used vegetal products in the treatment of breast
cancer [29]. In a more comprehensive ethnopharmacological study conducted in the same region that
included 150 herbalists, traditional healers, and rural dwellers, Jaradat et al. statistically observed
that 72 plants have been employed for treatment of this pathology, with the most represented families
being Compositae and Lamiaceae. The analysis showed that lung cancer was the type of malignancy
most often treated with plants, and that Ephedra alata was the most frequently used phytomedicine
for the management of cancer in Palestine [30,31]. The novelty of this study from the point of view
of anticancer evaluation is the fact that, in the set experimental parameters, EA exhibits important
antiproliferative, and weak pro-apoptotic and cytotoxic, potential against the MCF-7 human breast
cancer cell line. So, the results from the abovementioned ethnopharmacological studies are supported
by our experimental data, which attest to the in vitro anticancer activity of EA by mechanisms that
involve the inhibition of proliferation.
4. Materials and Methods
4.1. Plant Materials
Dried aerial parts of Ephedra alata Decne. were bought in Romania from the southern part of
Tunisia (Djerba) by a student of the Victor Babes¸ University of Medicine and Pharmacy, identified in
the department of Pharmacognosy, and assigned the voucher specimen code Ea 12/2018. Some of
the dried aerial parts were ground with the help of a commercial blender. From the powder, 10 g
were weighted, and 50 mL of 70% ethanol were added. The extraction was conducted in an ultrasonic
bath (FALC LBS2, Treviglio, Italia) for 30 min at a frequency of 40 kHz and a temperature of 50 ◦ C.
The extract was then filtered with a vacuum pump. The solvent was evaporated to dryness in a rotary
evaporator (250 bar pressure, temperature 60 ◦ C, and 150 rpm). The extract (EA) was stored at −4 ◦ C
until use.
4.2. Determination of Total Polyphenols Content (TP)
From the previously obtained extract, 0.1 g were dissolved in 1 mL methanol and ultrasonicated
for 30 min using an Aqua Wave 9381 (Barnstead Lab Line, Thermo Fisher Inc.). A 0.5 mL amount of
alcoholic extract was treated with 1.25 mL of Folin–Ciocalteu (Merck, Darmstadt, Germany) reagent
diluted 1:10 with water. The sample was incubated for 5 mins at room temperature, and 1 mL of 60 g/L
Na2CO3 (S.C.Chemical Company S.A., Bucuresti, Romania) was added. After 30 min of incubation
at 50 ◦C, the absorbance of the samples was measured at 750 nm using a UV-VIS spectrophotometer
(Analytic Jena Specord 205, Jena, Germany). The calibration curve was obtained using gallic acid
(GA) (Sigma Aldrich Chemie, Madrid, Spain) as a standard (concentration range 5–250 µg/mL) and a
blank ethanol control (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany). The regression equation
was: y = 1.92x − 0.10, and the coefficient of correlation R2 = 0.9980. The results were expressed in mg
GAE·g−1 extract. All experiments were performed in triplicate.
4.3. Determination of Individual Polyphenols by LC-MS
For individual polyphenols identification, two hydroalcoholic extracts of EA were tested. The first
extract was obtained in a concentration of 50 mg/mL after dissolving the extract prepared according to
Section 4.1. in 70% ethanol. The second extract was obtained in a concentration of 10 mg/mL
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in methanol:water:formic acid (90:8:2, v/v/v). For the determination of individual polyphenols,
a Shimadzu Chromatograph equipped with SPD-10A UV and LC-MS 2010 detectors was used.
The chromatographic conditions were as follows: mobile phases A: water acidified with formic
acid at pH 3; B: acetonitrile acidified with formic acid at pH 3; gradient program: 0.01–20 min, 5%
B; 20.01–50 min, 5–40% B; 50–55 min, 40–95% B; and 55–60 min 95% B. The solvent flow rate was
0.3 ml/min at 20 ◦C. The monitoring wavelength was 280–320 nm. Two chromatographic columns were
used: an Adsorbosphere UHS C18, 5 µm, Lot no.007250 (Column I) and an EC 150/2 NUCLEODUR
C18 Gravity SB 150 × 2 mm × 5 µm column, ref:760618.20, SN E 15110907, Lot 38775055 (Column II).
The calibration curves were performed in the range of 20–50 µg/mL. The results were expressed in
mg·g−1 d.m. Experiments were performed in duplicate. All standards were prepared in methanol
(Merck KGaA), and all reagents and solvents used were of analytical grade. Standards of polyphenols
were purchased from Sigma-Aldrich, Merck KGaA. The calibration curve and m/z signal are presented
in Table 1.
4.4. Determination of the Total Antioxidant Activity (AA)
For the determination of the antioxidant activity (AA), the CUPRAC method was employed.
The CUPRAC method is a spectrophotometric technique that depends upon the reduction
of a cupric neocuproine complex to a cuprous neocuproine complex by a reductant at low
pH [32]. The neocuproine complex can be monitored at 450 nm. As a reference substance, Trolox
(6-hydroxy-2,5,7,8-tetramethilcroman-2-carboxylic acid) (Sigma-Aldrich; Merck KGaA, Darmstadt,
Germany), an antioxidant with a structure similar to vitamin E, was used. Reagents: 0.01 M
CuCl2 (S.C.Chemical Company S.A., Bucuresti, Romania), 7.5 × 10−3 M, neocuproine
(2,9-Dimethyl-1,10-phenanthroline) (Sigma–Aldrich, Germany), and acetate buffer. One milliliter
(1 mL) of 0.01 M CuCl2 solution was mixed with 1 mL neocuproine (7.5 × 10−3) and 1 mL of acetate
buffer. At this solution, 1.1 mL of sample (alcoholic extract) was added. For the blank, 50% ethanol was
used. The absorption was read after 0.5 hours at 20 ◦C at 450 nm. All determinations were performed
in triplicate.
4.5. Determination of Total Alkaloids (TA)
The determination of total alkaloids (TA) was done using the ninhydrin reaction according the
method described by Ibragic and Sofic 2015 [5]. Ninhydrin reacts with aminoacid groups and yields a
violet-blue compound with a maximum absorbance at 570 nm. Ninhydrin solution (2%) was prepared
in ethanol and adjusted to pH 7.8–7.9 with Na2CO3 6 g/L. One hundred microliters (100 µL) of
ninhydrin solution was added to 100 µL of extract, obtained as described in Section 4.1., and the
volume was filled to 1 mL with ethanol. The absorbance of the coloured compound was read at
570 nm using a UV-VIS spectrophotometer (Analytic Jena Specord 205). The calibration curve was
obtained from Ephedrine stock solution (50 mg/mL, Zentiva SA, Bucuresti, Romania). It was used
to obtain serial standard dilution samples in a concentration that ranged between 12 and 32 µg/mL.
The determinations were performed in triplicate. The coefficient of correlation for the calibration curve
was R2 = 0.9547. The results were expressed in mg ephedrine/g extract.
4.6. In Vitro Antimicrobial Activity
The EA at the concentration of 30 µg/mL was screened for its antimicrobial activity against seven
bacterial and two fungus strains. Reference strains see Table 5.
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Table 5. Reference strains.
Bacterial Species ATCC Producer
Salmonella enterica serotype typhimurium 14,028 Thermo Scientific
Shigella flexneri serotype 2b 12,022 Thermo Scientific
Enterococcus faecalis 51,299 Thermo Scientific
Escherichia coli 25,922 Thermo Scientific
Klebsiella pneumoniae 700,603 Thermo Scientific
Pseudomonas aeruginosa 27,853 Thermo Scientific
Staphylococcus aureus 25,923 Thermo Scientific
Candida albicans 10,231 Thermo Scientific
Candida parapsilosis 22,019 Thermo Scientific
4.7. Disk Diffusion Method
The antimicrobial activity of the extract was evaluated, as previously described, by the agar disk
diffusion method [33,34]. Mueller–Hinton agar plates (Sanimed, Bucharest, Romania) were inoculated
with 100 µL of a microbial suspension (108 germs/mL) in physiological saline. Ten microliters, from
each sample, were placed on a blank paper disk (BioMaxima, Lublin, Poland), then deposited onto the
surface of the cultured media. Agar plates inoculated with the microbial suspensions were incubated
at 37 ◦C for 24 h. The reading of the inhibition diameters was made in millimeters with a ruler.
For all bacterial strains, the disk-diffusion tests were performed in triplicate. The positive control
was represented by gentamycin or fluconazole disks (Bio-Rad, Marnes-la-Coquette, France). For the
negative control, we used a blank paper disk impregnated with DMSO.
4.8. Determination of the Minimum Inhibitory Concentration (MIC) and the Minimum Bactericidal
Concentration (MBC)
The EA was tested by a broth dilution assay, as recommended by the Clinical Laboratory and
Standard Institute (CLSI). A concentration of 200 µg/Ml was prepared. In five test tubes, serial 2-fold
dilutions in Mueller–Hinton broth (Sanimed, Bucharest, Romania) of the EA were done. The test tubes
were inoculated with 5 × 105 bacteria/ml. After incubating the test tubes at 37 ◦C for 24 h, the MIC
(the lowest concentration that yielded no growth) was determined. In addition, the test tubes with no
visible growth were inoculated on Columbia agar +5% sheep’s blood or Sabouraud chloramphenicol
agar (Sanimed, Bucharest, Romania) in order to determine the MBC (the lowest concentration that
killed 99.9% of the initial inoculum). The medium plates were incubated at 37 ◦C for 24 h, and the
MBC was determined [35].
4.9. Cell Culture
The cells used in this study were MCF-7 human breast cancer cells purchased from ATCC
(American Type Culture Collection; code no ATCC® HTB-22TM) as a frozen vial. The cell line
was cultured in specific growth medium Eagle’s Minimum Essential Medium (EMEM, code no
ATCC® 30-2003™) supplemented with 10% FBS (fetal bovine serum) and 1% antibiotics mixture of
penicillin/streptomycin (Sigma-Aldrich, Munich, Germany). The cells were maintained in a standard
condition: a humidified atmosphere with 5% CO2 at 37 ◦C in a Steri-Cycle i160 incubator (Thermo
Fisher Scientific, USA), and supervised daily.
4.10. Antiproliferative MTT Assay
The assessment of the antiproliferative activity was conducted as previously described [36]. The cells
were plated at a density of 5000 cells/well using 96-well plates and incubated with selected concentrations
of EA. After 72 h of incubation, 5 mg/mL MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) solution was added and incubated for another 4 h. The absorbance of the precipitated formazan
crystals dissolved in dimethyl sulfoxide (DMSO) was measured with a microplate reader at 545 nm.
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Wells with cells incubated with medium and DMSO were used as a control [37]. The results are presented
as the mean of three different experiments.
4.11. Anti-Migratory Potential: A Wound Healing Technique
In order to study the migration of MCF-7 cells after treatment with the EA extract and DMSO,
respectively, the in vitro scratch assay method was applied. This is an economical, accessible,
and undemanding technique to express cell-to-cell interactions [38,39].
A number of 2 × 105 cells was plated onto a 12-well culture plate and allowed to attach to the
bottom of the plate until a confluent cell monolayer was formed. After that, an artificial gap was made
with a sterile tip in the middle of each well. All the cellular debris and detached cells were washed
with 1.5 mL PBS/well. Further, the cells were treated with EA extract (30 µg/mL) and DMSO, used
in an equal volume, as the test compound. The gap filling was supervised by taking pictures of the
scratched area at 0, 3, and 24 h. Photographs were performed at a magnification of 10× using an
inverted microscope (Olympus IX73, Tokyo, Japan) equipped with a DP74 camera. Scratch surfaces
were analyzed with the CellSense Dimension software (Version 1.17, Olympus, Tokyo, Japan) and the
migration percentage was determined according to the formula described by Felice et al. [40].
4.12. Determination of the Cytotoxic Potential by the Means of Lactate Dehydrogenase (LDH) Assay
The cytotoxic rate of the EA extract at the highest concentration (30 µg/mL) was determined
by quantification of the LDH leakage into the media when cellular membrane damage emerged.
The protocol was almost the same as the one used for the cell viability assessment, with the exception
that, on the day of the assay, 50 µL from each well was transferred to a new 96-well plate and mixed
with reaction mixture (50 µL/well), followed by an incubation of 30 min at room temperature. After this
step, 50 µL/well of stop solution was added, and the level of LDH released into the medium was
determined by measuring the absorbance of the wells at the wavelengths of 490 nm and 680 nm using
a microplate reader (xMarkTM Microplate, Biorad). A Positive Control was prepared by combining
1 µL of LDH Positive Control with 10 mL of FCS in PBS (to a final concentration of 1% FCS).
4.13. DAPI: Cell Nuclei Staining
MCF-7 cells cultured in a 6-well plate were stimulated with EA extract (30 µg/mL) for 72 h.
At the end of the incubation period, the cells were washed two times with ice-cold PBS and fixed with
4% paraformaldehyde in PBS for 30 min. Fixed cells were washed again with PBS, permeabilized
with 2% Triton X-100 (Sigma) for 30 min, and blocked with 30% FCS in 0.01% Triton X-100 for 1 h.
The final step consisted in staining the cells with DAPI (4’,6’-diamidino–2-phenylindole) in a dark
chamber for 15 min. Cell nuclei were analyzed at a magnification of 40× with a fluorescence Olympus
IX73 microscope equipped with an integrated DP74 camera (Olympus, Tokyo, Japan).
4.14. Annexin V-PI Assay
A number of 5× 105 cells/well were seeded into a 6-well plate (Greiner bio-one) and left overnight
in order to attach to the bottom of the plate. After 24 h, the cultured medium was removed, and a
fresh medium containing the tested extracts at a concentration of 30 µg/mL was added. The final
concentration of the tested compounds was obtained by successive dilutions into the culture medium,
starting from a stock solution of 10 mg/mL (extract) in DMSO. Untreated cells were used as a control;
cells treated with DMSO were used as a solvent control. After 72 h, the cells were trypsinized and
analyzed for the apoptotic effect of EA extract using flow cytometry. Annexin V-FITC combined with a
propidium iodide (PI) kit (Invitrogen, ThermoFisher, Vienna, Austria) was used in the cell death flow
cytometric studies (apoptosis) following the manufacturer’s protocol. Briefly, 2–5 × 105 cells were
washed two times in 1× Annexin V Binding Buffer, centrifuged at 1500 RPM for 5 min, resuspended in
the binding buffer, and incubated with 5 µL of Annexin V-FITC for 15 min in the dark. After washing
the cells with 200 µL specific binding buffer and centrifugation, the cell pellet was resuspended in
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190 µL binding buffer, and 10 µL of PI solution was added immediately prior to the analysis by flow
cytometry. The results are presented as the mean of three different experiments ± standard deviation.
4.15. Statistics
The Prism software package GraphPad Prism 5.01 (GraphPad Software, San Diego, CA, USA)
was used for data collection and presentation. The data ranged from three to six separate experiments,
and are presented as mean ± SD. Statistical significance was assessed by one-way ANOVA fallowed
by a Newman–Keuls post-hoc test for the comparison of multiple groups. *, **, ***, and **** indicate
p < 0.05, p < 0.01, p < 0.001, and p < 0.0001, respectively, compared to the control group.
5. Conclusions
Ethanolic extracts of the aerial part of Ephedra alata Decne., which is indigenous to the southern part
of Tunisia (Djerba), contain polyphenolic phytocompounds and elicit antioxidant activity. The LC-MS
results show that, among the screened polyphenolic compounds, the extract contains kaempherol,
epicatechin, and quercetin. The extract acts as a bacteriostatic agent against all tested bacterial strains
(K. pneumoniae,→ S. flexneri, S.enterica,→ E. coli, P.aeruginosa,→ S. aureus, E. faecalis C. albicans, and
.parapsilosis); however, it is bactericidal only against the Gram-positive cocci and Candida spp. In the set
of experimental conditions, the hydroalcoholic extract has a potential antiproliferative, pro-apoptotic,
and cytotoxic effect against the MCF-7 human breast cancer cell line.
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